Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1991 Oct 15;279(Pt 2):427–433. doi: 10.1042/bj2790427

Polymorphism of apolipoprotein A-II (apoA-II) among inbred strains of mice. Relationship between the molecular type of apoA-II and mouse senile amyloidosis.

K Higuchi 1, K Kitagawa 1, H Naiki 1, K Hanada 1, M Hosokawa 1, T Takeda 1
PMCID: PMC1151622  PMID: 1683229

Abstract

Three types of apolipoprotein A-II (apoA-II) proteins (A, B and C) were predicted from the nucleotide sequence of apoA-II cDNA. Substitution of amino acid residues was noted at four positions (type A: Pro-5, Asp-20, Met-26, Ala-38; B: Pro-5, Glu-20, Val-26, Val-38; C: Gln-5, Glu-20, Val-26, Ala-38). Each type was identifiable by digestion of amplified apoA-II DNA by PCR, using restriction-fragment-length polymorphism of the apoA-II gene for restriction enzymes Cfr13I and MspI. The molecular type of apoA-II was determined among 23 strains of mice including nine of the senescence accelerated mouse series developed in our laboratory. Examination of types of apoA-II and amyloid deposition in the F2 and F3 hybrid mice showed that apoA-II amyloid deposition was present only in the mice homozygous for type C apoA-II and which were 12-17 months of age. The molecular type of apoA-II may be a factor involved in the development of senile amyloidosis in mice.

Full text

PDF
427

Images in this article

431Fig. 3.
on p.431
431Fig. 4.
on p.431

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anantharamaiah G. M., Hughes T. A., Iqbal M., Gawish A., Neame P. J., Medley M. F., Segrest J. P. Effect of oxidation on the properties of apolipoproteins A-I and A-II. J Lipid Res. 1988 Mar;29(3):309–318. [PubMed] [Google Scholar]
  2. Chen W. H., Hosokawa M., Tsuboyama T., Ono T., Iizuka T., Takeda T. Age-related changes in the temporomandibular joint of the senescence accelerated mouse. SAM-P/3 as a new murine model of degenerative joint disease. Am J Pathol. 1989 Aug;135(2):379–385. [PMC free article] [PubMed] [Google Scholar]
  3. Cornwell G. G., 3rd, Sletten K., Johansson B., Westermark P. Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin. Biochem Biophys Res Commun. 1988 Jul 29;154(2):648–653. doi: 10.1016/0006-291x(88)90188-x. [DOI] [PubMed] [Google Scholar]
  4. Doolittle M. H., LeBoeuf R. C., Warden C. H., Bee L. M., Lusis A. J. A polymorphism affecting apolipoprotein A-II translational efficiency determines high density lipoprotein size and composition. J Biol Chem. 1990 Sep 25;265(27):16380–16388. [PubMed] [Google Scholar]
  5. Glenner G. G., Page D. L. Amyloid, amyloidosis, and amyloidogenesis. Int Rev Exp Pathol. 1976;15:1–92. [PubMed] [Google Scholar]
  6. Gorevic P. D., Prelli F. C., Wright J., Pras M., Frangione B. Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. J Clin Invest. 1989 Mar;83(3):836–843. doi: 10.1172/JCI113966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Higuchi K., Matsumura A., Honma A., Takeshita S., Hashimoto K., Hosokawa M., Yasuhira K., Takeda T. Systemic senile amyloid in senescence-accelerated mice. A unique fibril protein demonstrated in tissues from various organs by the unlabeled immunoperoxidase method. Lab Invest. 1983 Feb;48(2):231–240. [PubMed] [Google Scholar]
  8. Higuchi K., Yonezu T., Kogishi K., Matsumura A., Takeshita S., Higuchi K., Kohno A., Matsushita M., Hosokawa M., Takeda T. Purification and characterization of a senile amyloid-related antigenic substance (apoSASSAM) from mouse serum. apoSASSAM is an apoA-II apolipoprotein of mouse high density lipoproteins. J Biol Chem. 1986 Sep 25;261(27):12834–12840. [PubMed] [Google Scholar]
  9. Higuchi K., Yonezu T., Tsunasawa S., Sakiyama F., Takeda T. The single proline-glutamine substitution at position 5 enhances the potency of amyloid fibril formation of murine apo A-II. FEBS Lett. 1986 Oct 20;207(1):23–27. doi: 10.1016/0014-5793(86)80006-0. [DOI] [PubMed] [Google Scholar]
  10. Hosokawa M., Kasai R., Higuchi K., Takeshita S., Shimizu K., Hamamoto H., Honma A., Irino M., Toda K., Matsumura A. Grading score system: a method for evaluation of the degree of senescence in senescence accelerated mouse (SAM). Mech Ageing Dev. 1984 Jul;26(1):91–102. doi: 10.1016/0047-6374(84)90168-4. [DOI] [PubMed] [Google Scholar]
  11. Husby G., Sletten K. Chemical and clinical classification of amyloidosis 1985. Scand J Immunol. 1986 Mar;23(3):253–265. doi: 10.1111/j.1365-3083.1986.tb01966.x. [DOI] [PubMed] [Google Scholar]
  12. Innis M. A., Myambo K. B., Gelfand D. H., Brow M. A. DNA sequencing with Thermus aquaticus DNA polymerase and direct sequencing of polymerase chain reaction-amplified DNA. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9436–9440. doi: 10.1073/pnas.85.24.9436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jahn C. E., Osborne J. C., Jr, Schaefer E. J., Brewer H. B., Jr Activation of the enzymic activity of hepatic lipase by apolipoprotein A-II. Characterization of a major component of high density lipoprotein as the activating plasma component in vitro. Eur J Biochem. 1983 Mar 1;131(1):25–29. doi: 10.1111/j.1432-1033.1983.tb07227.x. [DOI] [PubMed] [Google Scholar]
  14. Koeger A. C., Branellec A., Hirbec G., Blouquit Y., Mouriquand C., Sobel A., Lagrue G. Etude biologique de l'amylose spontanée de la souris PS. Pathol Biol (Paris) 1984 Nov;32(9):959–964. [PubMed] [Google Scholar]
  15. Kohno A., Yonezu T., Matsushita M., Irino M., Higuchi K., Higuchi K., Takeshita S., Hosokawa M., Takeda T. Chronic food restriction modulates the advance of senescence in the senescence accelerated mouse (SAM). J Nutr. 1985 Oct;115(10):1259–1266. doi: 10.1093/jn/115.10.1259. [DOI] [PubMed] [Google Scholar]
  16. Kunisada T., Higuchi K., Aota S., Takeda T., Yamagishi H. Molecular cloning and nucleotide sequence of cDNA for murine senile amyloid protein: nucleotide substitutions found in apolipoprotein A-II cDNA of senescence accelerated mouse (SAM). Nucleic Acids Res. 1986 Jul 25;14(14):5729–5740. doi: 10.1093/nar/14.14.5729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lusis A. J., Taylor B. A., Wangenstein R. W., LeBoeuf R. C. Genetic control of lipid transport in mice. II. Genes controlling structure of high density lipoproteins. J Biol Chem. 1983 Apr 25;258(8):5071–5078. [PubMed] [Google Scholar]
  18. Matsumura A., Higuchi K., Shimizu K., Hosokawa M., Hashimoto K., Yasuhira K., Takeda T. A novel amyloid fibril protein isolated from senescence-accelerated mice. Lab Invest. 1982 Sep;47(3):270–275. [PubMed] [Google Scholar]
  19. Matsushita M., Tsuboyama T., Kasai R., Okumura H., Yamamuro T., Higuchi K., Higuchi K., Kohno A., Yonezu T., Utani A. Age-related changes in bone mass in the senescence-accelerated mouse (SAM). SAM-R/3 and SAM-P/6 as new murine models for senile osteoporosis. Am J Pathol. 1986 Nov;125(2):276–283. [PMC free article] [PubMed] [Google Scholar]
  20. Miyamoto M., Kiyota Y., Yamazaki N., Nagaoka A., Matsuo T., Nagawa Y., Takeda T. Age-related changes in learning and memory in the senescence-accelerated mouse (SAM). Physiol Behav. 1986;38(3):399–406. doi: 10.1016/0031-9384(86)90112-5. [DOI] [PubMed] [Google Scholar]
  21. Pitkänen P., Westermark P., Cornwell G. G., 3rd Senile systemic amyloidosis. Am J Pathol. 1984 Dec;117(3):391–399. [PMC free article] [PubMed] [Google Scholar]
  22. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  23. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Scheinberg M. A., Cathcart E. S., Eastcott J. W., Skinner M., Benson M., Shirahama T. The SJL/J mouse: a new model for spontaneous age-associated amyloidosis. I. Morphologic and immunochemical aspects. Lab Invest. 1976 Jul;35(1):47–54. [PubMed] [Google Scholar]
  25. THUNG P. J. Senile amyloidosis in mice. Gerontologia. 1957;1(5):259–279. doi: 10.1159/000210704. [DOI] [PubMed] [Google Scholar]
  26. Takeda T., Hosokawa M., Takeshita S., Irino M., Higuchi K., Matsushita T., Tomita Y., Yasuhira K., Hamamoto H., Shimizu K. A new murine model of accelerated senescence. Mech Ageing Dev. 1981 Oct;17(2):183–194. doi: 10.1016/0047-6374(81)90084-1. [DOI] [PubMed] [Google Scholar]
  27. Takeshita S., Hosokawa M., Irino M., Higuchi K., Shimizu K., Yasuhira K., Takeda T. Spontaneous age-associated amyloidosis in senescence-accelerated mouse (SAM). Mech Ageing Dev. 1982 Sep;20(1):13–23. doi: 10.1016/0047-6374(82)90070-7. [DOI] [PubMed] [Google Scholar]
  28. Tawara S., Nakazato M., Kangawa K., Matsuo H., Araki S. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun. 1983 Nov 15;116(3):880–888. doi: 10.1016/s0006-291x(83)80224-1. [DOI] [PubMed] [Google Scholar]
  29. Wallace M. R., Dwulet F. E., Williams E. C., Conneally P. M., Benson M. D. Identification of a new hereditary amyloidosis prealbumin variant, Tyr-77, and detection of the gene by DNA analysis. J Clin Invest. 1988 Jan;81(1):189–193. doi: 10.1172/JCI113293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Yagi H., Irino M., Matsushita T., Katoh S., Umezawa M., Tsuboyama T., Hosokawa M., Akiguchi I., Tokunaga R., Takeda T. Spontaneous spongy degeneration of the brain stem in SAM-P/8 mice, a newly developed memory-deficient strain. J Neuropathol Exp Neurol. 1989 Sep;48(5):577–590. doi: 10.1097/00005072-198909000-00008. [DOI] [PubMed] [Google Scholar]
  31. Yonezu T., Higuchi K., Tsunasawa S., Takagi S., Sakiyama F., Takeda T. High homology is present in the primary structures between murine senile amyloid protein (ASSAM) and human apolipoprotein A-II. FEBS Lett. 1986 Jul 28;203(2):149–152. doi: 10.1016/0014-5793(86)80732-3. [DOI] [PubMed] [Google Scholar]
  32. Yonezu T., Toda M., Yamagishi H., Higuchi K., Takeda T. Structural organization of the gene encoding apolipoprotein A-II in an amyloidotic strain of senescence-accelerated mouse. Gene. 1989 Dec 7;84(1):187–191. doi: 10.1016/0378-1119(89)90154-6. [DOI] [PubMed] [Google Scholar]
  33. Yonezu T., Tsunasawa S., Higuchi K., Kogishi K., Naiki H., Hanada K., Sakiyama F., Takeda T. A molecular-pathologic approach to murine senile amyloidosis. Serum precursor-apolipoprotein A-II variant (Pro5----Gln) presents only in the senile amyloidosis-prone SAM-P/1 and SAM-P/2 mice. Lab Invest. 1987 Jul;57(1):65–70. [PubMed] [Google Scholar]
  34. Zschiesche W. Spontaneous amyloidosis of the mouse. 3. Two patterns of amyloid distribution and their pathogenic relationship. Acta Pathol Microbiol Scand Suppl. 1972;233:135–140. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES